Colonial Trust Advisors’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Colonial Trust Advisors's EDIT Position: Q3 2026 in Review
Colonial Trust Advisors held its Editas Medicine (EDIT) position steady in Q3 2026 at 30 shares worth $77. The position accounts for ﹤0.01% of the portfolio, ranked #835.
Colonial Trust Advisors first reported a position in EDIT in Q4 2022 and has held it in 16 quarters since. The position peaked at $304 in Q4 2023. 220 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.
- Colonial Trust Advisors held 30 shares of Editas Medicine worth $77 as of Q3 2026.
- Colonial Trust Advisors left its Editas Medicine share count unchanged in Q3 2026.
- Editas Medicine made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q3 2026, its #835 holding.
- Colonial Trust Advisors first reported a position in Editas Medicine in Q4 2022 and has held it in 16 quarters since.
- Colonial Trust Advisors's Editas Medicine position peaked at $304 in Q4 2023.
- 220 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.
Based on Colonial Trust Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.